Diabetic neuropathy epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 2: | Line 2: | ||
{{Diabetic neuropathy}} | {{Diabetic neuropathy}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Diabetes is the leading known | Diabetes is the leading known cause of neuropathy in developed countries, and neuropathy is the most common complication and greatest source of [[morbidity]] and [[death|mortality]] in diabetes patients. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
It is estimated that the [[prevalence]] of neuropathy in diabetes patients is approximately 20%. Diabetic neuropathy is implicated in 50-75% of nontraumatic [[amputation]]s. | |||
In the DCCT (Diabetes Control and Complications Trial, 1995) study, the annual incidence of neuropathy was 2% per year, but dropped to 0.56% with intensive treatment of Type 1 diabetics. | |||
The largest group of neuropathy patients are of unknown cause, referred to as [[idiopathic]] in origin. Of the roughly 100 known causes, diabetes is by far the largest. Other known causes include genetic factors, damaging chemical agents such as chemotherapy drugs, and HIV. | The largest group of neuropathy patients are of unknown cause, referred to as [[idiopathic]] in origin. Of the roughly 100 known causes, diabetes is by far the largest. Other known causes include genetic factors, damaging chemical agents such as chemotherapy drugs, and HIV. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
| Line 15: | Line 18: | ||
{{WS}} | {{WS}} | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category: | [[Category:Needs content]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
Latest revision as of 17:40, 25 July 2016
|
Diabetic neuropathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Diabetic neuropathy epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Diabetic neuropathy epidemiology and demographics |
|
Diabetic neuropathy epidemiology and demographics in the news |
|
Risk calculators and risk factors for Diabetic neuropathy epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Diabetes is the leading known cause of neuropathy in developed countries, and neuropathy is the most common complication and greatest source of morbidity and mortality in diabetes patients.
Epidemiology and Demographics
It is estimated that the prevalence of neuropathy in diabetes patients is approximately 20%. Diabetic neuropathy is implicated in 50-75% of nontraumatic amputations.
In the DCCT (Diabetes Control and Complications Trial, 1995) study, the annual incidence of neuropathy was 2% per year, but dropped to 0.56% with intensive treatment of Type 1 diabetics.
The largest group of neuropathy patients are of unknown cause, referred to as idiopathic in origin. Of the roughly 100 known causes, diabetes is by far the largest. Other known causes include genetic factors, damaging chemical agents such as chemotherapy drugs, and HIV.